National Kidney Foundation and Abbott

New York, NY (November 29, 2006) - The National Kidney Foundation (NKF) and Abbott's Ross Products Division announced today a joint partnership to develop educational programs that focus on nutrition and chronic kidney disease. The new initiative, which is part of NKF’s “Partners in Education Program,” will feature print and online educational programs for both patients and health care professionals. In addition, Abbott will be identified with the NKF’s Kidney Early Evaluation Program (KEEP), a free health screening for those at risk of chronic kidney disease. All educational programs will be developed by the NKF and promoted through its Kidney Learning System. Abbott will promote the new partnership by displaying the NKF’s logo on the product labels of its two nutritional supplements for people with kidney disease, Nepro™ and Suplena™.

“Malnutrition is common in patients with chronic kidney disease,” says Allan Collins, MD, president of the National Kidney Foundation. “Recent studies have shown that it is an issue even for patients who are not yet receiving dialysis treatment and that those who suffer malnutrition before dialysis have a greater risk of death from cardiovascular disease. Maintaining good nutritional status is critically important for all people with chronic kidney disease.”

"Our company has a longstanding commitment to educating health care professionals and their patients about the important role nutrition plays in health maintenance and disease management," states Gary McCullough, president of Abbott's Ross Products Division. "We are pleased to be partners with the National Kidney Foundation for this nationwide initiative that will benefit people living with Chronic Kidney Disease."

Chronic kidney disease (CKD) is a condition where the kidneys are no longer able to filter toxins from the blood to sustain healthy body function.


About National Kidney Foundation

The National Kidney Foundation is the nation's largest voluntary agency dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well being of individuals and families affected by these diseases and increasing the availability of all organs for transplantation. To receive free copies of "Nutrition and Chronic Kidney Disease in the Early Stages: Are You Getting What You Need?" and "Nutrition and Dialysis: Are You Getting What You Need?", contact the National Kidney Foundation at (800) 622-9010.

About Abbott

Abbott is committed to ongoing innovation in the area of chronic kidney disease. Abbott produces two nutritional supplements for people with kidney disease: Nepro and Suplena. Nepro is specifically designed and clinically shown to support the nutritional needs and altered metabolism of people on dialysis. Suplena is a low-protein, high-calorie nutritionally complete formula with a vitamin and mineral profile specifically designed for people in earlier stages of chronic kidney disease who are not receiving dialysis. The company also markets oral and IV-form activated vitamin D medications to address the needs of both CKD and dialysis patients.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at